Yes, you read that right: Billions of dollars are being spent on elbow injuries, (Tennis Elbow in particular) globally every single year! And it’s on the rise in both prevalence (more injuries) and treatment costs.
Market research / data-gathering firms giddily announce that these treatment costs are projected to reach 10 BILLION dollars annually by 2022!
(But how much of that is spent on “symptom chasing” as opposed to truly treating the underlying injury?)
MedGadget.com reveals that:
“According to the National Institute for Health and Care Excellence (NICE) tennis elbow was prevalent in 1%-3% of UK population in 2012. It has been observed that people above 60 years are more afflicted with elbow pain.”
“Therefore, rapidly growing geriatric population and increasing incidence of arm fracture due to accidents are expected to drive growth of the elbow lesion market in the near future.”
Read more about the “Elbow Lesion Market” – Via medgadget.com
Sadly, it appears that most of these billions are being spent on Cortisone Shots and NSAID type Anti-inflammatory medications.
This is particularly unfortunate, since these drugs only “treat” (suppress) the symptoms of Tennis Elbow and Golfer’s Elbow and do nothing whatsoever to treat the injuries themselves.
“Among the treatment types, Corticosteroid injections segment is the most prominent market in terms of revenue.”
“However, non-surgical therapies such as platelet rich plasma (PRP), splint elbow brace, ice packs and others will take approximately 40% market share in 2015.”
“It is reported that around 95% of the total tennis elbow patients get relief from these therapies and do not need to opt for other medications and or surgical procedures.”
The article also states that the effectiveness of Platelet Rich Plasma Injection Therapy is being investigated as a possible treatment for a variety of tendon injuries.
For a detailed look at the question of how effective that procedure is looking at the moment, see my article on Platelet Rich Plasma for the treatment of Tennis Elbow here
Despite the claim that “95% of tennis elbow patients get relief from non-surgical therapies” many of those Tennis Elbow injury sufferers are suffering for up to a year.
For the +/- 5% who end up facing – if not choosing surgery – there’s a tough decision to be made. And if that’s something you’re starting to wonder about yourself, see my article about surgery for Tennis Elbow:
Much of this data seems to be drawn from ‘Credence Research’ whose data suggests that “more than 30 billion over the counter tablets that are annually being sold in the U.S.” (Of NSAID type Anti-inflammatory medications for these kinds of injuries and others.)
And they inform us that not only is this a “Western” problem, (as we might naturally otherwise imagine) demand for Tennis Elbow treatment is projected to increase in emerging economies, like China:
“In the next few years the demand for tennis elbow treatment is expected to increase significantly in the emerging economies such as China and Canada.”
“Geriatric population is growing with the rising global population, and rising sports events are leading to increase in number of sports injuries and these are expected to boost the industry in the coming years.”
Read more at the source here: Lateral Epicondylitis (Tennis Elbow) Market By Treatment Type – (Credenceresearch.com)